These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 27777940)
1. Epigenetic regulation of human Singh P; O'Connell M; Shubhashish S Stem Cell Investig; 2016; 3():51. PubMed ID: 27777940 [TBL] [Abstract][Full Text] [Related]
2. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications. O'Connell MR; Sarkar S; Luthra GK; Okugawa Y; Toiyama Y; Gajjar AH; Qiu S; Goel A; Singh P Sci Rep; 2015 Oct; 5():14983. PubMed ID: 26447334 [TBL] [Abstract][Full Text] [Related]
4. FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer. Sarkar S; O'Connell MR; Okugawa Y; Lee BS; Toiyama Y; Kusunoki M; Daboval RD; Goel A; Singh P Mol Cancer Res; 2017 Dec; 15(12):1678-1691. PubMed ID: 28851816 [TBL] [Abstract][Full Text] [Related]
5. Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability. Wielandt AM; Hurtado C; Moreno C M; Villarroel C; Castro M; Estay M; Simian D; Martinez M; Vial MT; Kronberg U; López-Köstner F Tumour Biol; 2020 Jul; 42(7):1010428320938492. PubMed ID: 32635826 [TBL] [Abstract][Full Text] [Related]
6. A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy. Sarkar S; Popov VL; O'Connell MR; Stevenson HL; Lee BS; Obeid RA; Luthra GK; Singh P Lab Invest; 2017 Oct; 97(10):1245-1261. PubMed ID: 28414327 [TBL] [Abstract][Full Text] [Related]
7. The CpG island methylator phenotype (CIMP) in colorectal cancer. Nazemalhosseini Mojarad E; Kuppen PJ; Aghdaei HA; Zali MR Gastroenterol Hepatol Bed Bench; 2013; 6(3):120-8. PubMed ID: 24834258 [TBL] [Abstract][Full Text] [Related]
8. Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers. An B; Kondo Y; Okamoto Y; Shinjo K; Kanemitsu Y; Komori K; Hirai T; Sawaki A; Tajika M; Nakamura T; Yamao K; Yatabe Y; Fujii M; Murakami H; Osada H; Tani T; Matsuo K; Shen L; Issa JP; Sekido Y Int J Cancer; 2010 Nov; 127(9):2095-105. PubMed ID: 20131317 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype. Bae JM; Kim JH; Kang GH Histol Histopathol; 2013 May; 28(5):585-95. PubMed ID: 23341177 [TBL] [Abstract][Full Text] [Related]
11. CpG Island Methylator Phenotype-High Colorectal Cancers and Their Prognostic Implications and Relationships with the Serrated Neoplasia Pathway. Rhee YY; Kim KJ; Kang GH Gut Liver; 2017 Jan; 11(1):38-46. PubMed ID: 27885175 [TBL] [Abstract][Full Text] [Related]
12. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers? Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418 [TBL] [Abstract][Full Text] [Related]
13. Patterns of genomic instability in gastric cancer: clinical implications and perspectives. Ottini L; Falchetti M; Lupi R; Rizzolo P; Agnese V; Colucci G; Bazan V; Russo A Ann Oncol; 2006 Jun; 17 Suppl 7():vii97-102. PubMed ID: 16760303 [TBL] [Abstract][Full Text] [Related]
14. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway. Kim JH; Bae JM; Cho NY; Kang GH Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113 [TBL] [Abstract][Full Text] [Related]
15. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Toyota M; Ohe-Toyota M; Ahuja N; Issa JP Proc Natl Acad Sci U S A; 2000 Jan; 97(2):710-5. PubMed ID: 10639144 [TBL] [Abstract][Full Text] [Related]
16. Association of JC virus T-antigen expression with the methylator phenotype in sporadic colorectal cancers. Goel A; Li MS; Nagasaka T; Shin SK; Fuerst F; Ricciardiello L; Wasserman L; Boland CR Gastroenterology; 2006 Jun; 130(7):1950-61. PubMed ID: 16762618 [TBL] [Abstract][Full Text] [Related]
17. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high. Ogino S; Kawasaki T; Kirkner GJ; Ohnishi M; Fuchs CS BMC Cancer; 2007 May; 7():72. PubMed ID: 17474983 [TBL] [Abstract][Full Text] [Related]
19. CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer. Cheng YW; Pincas H; Bacolod MD; Schemmann G; Giardina SF; Huang J; Barral S; Idrees K; Khan SA; Zeng Z; Rosenberg S; Notterman DA; Ott J; Paty P; Barany F Clin Cancer Res; 2008 Oct; 14(19):6005-13. PubMed ID: 18829479 [TBL] [Abstract][Full Text] [Related]
20. The role of DNA hypermethylation in human neoplasia. Toyota M; Issa JP Electrophoresis; 2000 Jan; 21(2):329-33. PubMed ID: 10675010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]